Unique ID issued by UMIN | UMIN000007543 |
---|---|
Receipt number | R000008894 |
Scientific Title | Study of the Effect of inhaled Short Acting Beta 2 Agonist(procaterol) on Breathlessness on Exertion in COPD patients. |
Date of disclosure of the study information | 2012/03/22 |
Last modified on | 2012/03/21 15:25:09 |
Study of the Effect of inhaled Short Acting Beta 2 Agonist(procaterol)
on Breathlessness on Exertion in COPD patients.
Study of procaterol on Breathlessness on exertion in COPD patients.
Study of the Effect of inhaled Short Acting Beta 2 Agonist(procaterol)
on Breathlessness on Exertion in COPD patients.
Study of procaterol on Breathlessness on exertion in COPD patients.
Japan |
COPD (Chronic Obstructive
Pulmonary Disease)
Pneumology |
Others
NO
To evaluate the effect of inhaled short acting beta 2 agonist(procaterol) on breathlessness on exertion and effort of Activities of Daily Living(ADL) with COPD patients.
Safety,Efficacy
Exploratory
Pragmatic
Not applicable
severity of Breathlessness in exertions(Shortness of Breath Questionaire)
Activities of Daily Living(ADL) using Actimarker
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
The usual adult dose is 20microg(2puffs)of procaterol hydrochloride hydrate. In the case of MEPTIN Kid Air use is 20microg(4puffs). The administration should be done about 15minutes before breathlessness on exertion is caused. The dosage may be adjusted according to the patient's age and severity of symptoms.
40 | years-old | <= |
Not applicable |
Male and Female
Patient will be eligible for inclusion in this study if all of the following criteria are met:
1.An outpatient with COPD, but do not change the state, during study.
2.A patient without experience of airway infection or exacerbation within 3 months.
3.Patients meet the COPD guidelines of the Japanese Respiratory Society. The GOLD stages are stage >= II
A patient will not be eligible for inclusion in this study if any of the following criteria
1. There is a current diagnosis of asthma, in the opinion of the investigator
2. Patients with contraindication of procaterol inhalation.
3. The investigator judge to exclude
40
1st name | |
Middle name | |
Last name | Atsushi Nagai |
Tokyo Women's Medical University
First Department of Medicine
8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan
03-3353-8111
1st name | |
Middle name | |
Last name | Hiromasa Ogawa |
Tohoku University school of Medicine
industrial medicine
2-1 Seiryo-cho, Aoba-ku, Sendai 980-8575, Japan
022-717-8006
Tokyo Women's Medical University
Tohoku University Hospital
Wakayama Medical University
Tohoku Rosai Hospital
Tokyo Women's Medical University
Tohoku University Hospital
Wakayama Medical University
Tohoku Rosai Hospital
Self funding
NO
和歌山県立医科大学(和歌山県)、東北大学大学病院(宮城県)、東北労災病院(宮城県)
2012 | Year | 03 | Month | 22 | Day |
Unpublished
Preinitiation
2012 | Year | 01 | Month | 23 | Day |
2012 | Year | 04 | Month | 01 | Day |
2012 | Year | 09 | Month | 01 | Day |
2012 | Year | 03 | Month | 21 | Day |
2012 | Year | 03 | Month | 21 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008894
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |